Regeneron Pharmaceuticals (REGN) Research & Development (2009 - 2026)
Regeneron Pharmaceuticals' quarterly Research & Development came in at $1.5 billion in Q1 2026, up 16.28% year-on-year from $1.3 billion in Q1 2025, and down 5.08% quarter-over-quarter from $1.6 billion in Q4 2025.
Regeneron Pharmaceuticals has reported Research & Development for 18 years, with the latest figure at $1.5 billion in Q1 2026.
- For the quarter ending Q1 2026, Research & Development rose 16.28% year-over-year to $1.5 billion; the trailing twelve-month figure through Mar 2026 stood at $6.1 billion (up 16.41% YoY), and the FY2025 full-year result was $5.9 billion, up 13.99% from the prior year.
- Research & Development for Q1 2026 stood at $1.5 billion, down from $1.6 billion in the prior quarter.
- The five-year high for Research & Development was $1.6 billion in Q4 2025, with the low at $794.3 million in Q2 2022.
- Average Research & Development over 5 years is $1.2 billion, with a median of $1.2 billion recorded in 2024.
- Year-over-year, Research & Development soared 41.42% in 2022 and advanced 6.33% in 2025.
- Tracing REGN's Research & Development over 5 years: stood at $1.0 billion in 2022, then advanced by 12.86% to $1.2 billion in 2023, then grew by 19.95% to $1.4 billion in 2024, then gained by 15.15% to $1.6 billion in 2025, then retreated by 5.08% to $1.5 billion in 2026.
- The last three Research & Development figures came in at $1.5 billion (Q1 2026), $1.6 billion (Q4 2025), and $1.5 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 626,092.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 4.32 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -101.30 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 1.46 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 961.60 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -2.30 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 1.54 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 364.87 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | 343.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.54 Bn |
| Dec 31, 2025 | 1.63 Bn |
| Sep 30, 2025 | 1.48 Bn |
| Jun 30, 2025 | 1.42 Bn |
| Mar 31, 2025 | 1.33 Bn |
| Dec 31, 2024 | 1.41 Bn |
| Sep 30, 2024 | 1.27 Bn |
| Jun 30, 2024 | 1.20 Bn |
| Mar 31, 2024 | 1.25 Bn |
| Dec 31, 2023 | 1.18 Bn |
| Sep 30, 2023 | 1.08 Bn |
| Jun 30, 2023 | 1.09 Bn |
| Mar 31, 2023 | 1.10 Bn |
| Dec 31, 2022 | 1.04 Bn |
| Sep 30, 2022 | 911.30 Mn |
| Jun 30, 2022 | 794.30 Mn |
| Mar 31, 2022 | 843.80 Mn |
| Dec 31, 2021 | 737.60 Mn |
| Sep 30, 2021 | 665.40 Mn |
| Jun 30, 2021 | 714.20 Mn |
| Mar 31, 2021 | 742.90 Mn |
| Dec 31, 2020 | 656.50 Mn |
| Sep 30, 2020 | 684.60 Mn |
| Jun 30, 2020 | 15.00 Mn |
| Mar 31, 2020 | 583.90 Mn |
| Dec 31, 2019 | 552.40 Mn |
| Sep 30, 2019 | 526.00 Mn |
| Jun 30, 2019 | 885.50 Mn |
| Mar 31, 2019 | 486.10 Mn |
| Dec 31, 2018 | -116.00 Mn |
| Sep 30, 2018 | 557.00 Mn |
| Jun 30, 2018 | 529.30 Mn |
| Mar 31, 2018 | 498.60 Mn |
| Dec 31, 2017 | 527.94 Mn |
| Sep 30, 2017 | 529.75 Mn |
| Jun 30, 2017 | 509.98 Mn |
| Mar 31, 2017 | 507.44 Mn |
| Dec 31, 2016 | 479.21 Mn |
| Sep 30, 2016 | 543.05 Mn |
| Jun 30, 2016 | 559.93 Mn |
| Mar 31, 2016 | 470.11 Mn |
| Dec 31, 2015 | 461.21 Mn |
| Sep 30, 2015 | 425.92 Mn |
| Jun 30, 2015 | 390.33 Mn |
| Mar 31, 2015 | 343.11 Mn |
| Dec 31, 2014 | 351.75 Mn |
| Sep 30, 2014 | 337.73 Mn |
| Jun 30, 2014 | 294.50 Mn |
| Mar 31, 2014 | 287.38 Mn |
| Dec 31, 2013 | 268.14 Mn |
| Sep 30, 2013 | 224.05 Mn |
| Jun 30, 2013 | 187.46 Mn |
| Mar 31, 2013 | 180.30 Mn |
| Dec 31, 2012 | 181.02 Mn |
| Sep 30, 2012 | 158.30 Mn |
| Jun 30, 2012 | 147.37 Mn |
| Mar 31, 2012 | 138.86 Mn |
| Dec 31, 2011 | 129.04 Mn |
| Sep 30, 2011 | 127.92 Mn |
| Jun 30, 2011 | 143.15 Mn |
| Mar 31, 2011 | 129.39 Mn |
| Dec 31, 2010 | 125.21 Mn |
| Sep 30, 2010 | 122.04 Mn |
| Jun 30, 2010 | 124.53 Mn |
| Mar 31, 2010 | 117.47 Mn |
| Dec 31, 2009 | 118.79 Mn |
| Sep 30, 2009 | 105.43 Mn |
| Jun 30, 2009 | 94.23 Mn |